Fourth Quarter 2025 Revenue totaled
Full Year 2025 Revenue totaled
Fourth Quarter 2025 Net Income Attributable to Common Stockholders totaled
Full Year 2025 Net Income Attributable to Common Stockholders totaled
Conference Call and Webcast Scheduled for
“Our fourth quarter results were in line with expectations, delivering AFFO of
Fourth Quarter 2025 Financial Highlights
- Total revenue of
$12.3 million . - Net income attributable to common stockholders totaled
$6.0 million , or$0.29 per share of common stock. - Funds From Operations(1) (“FFO”) totaled
$10.0 million or$0.48 per share of common stock. - Adjusted Funds From Operations(1) (“AFFO”) totaled
$10.6 million or$0.51 per share of common stock. - Declared a fourth quarter dividend of
$0.43 per share of common stock, equivalent to an annualized dividend of$1.72 per common share.
Full Year 2025 Financial Highlights
- Total revenue of
$51.1 million . - Net income attributable to common stockholders totaled
$26.3 million or$1.28 per share of common stock. - FFO(1) totaled
$42.3 million or$2.02 per share of common stock. - AFFO(1) totaled
$43.8 million or$2.09 per share of common stock. - For the twelve months ended
December 31, 2025 , the Company declared dividends of$1.72 per share of common stock.
Full Year 2025 Operational Highlights and Recent Developments
- During the year ended
December 31, 2025 , the Company purchased two dispensaries inOhio for approximately$0 .8 million and committed to fund approximately$1 .1 million of improvements, of which the Company funded approximately$0 .7 million as ofDecember 31, 2025 . The properties were leased to an existing tenant. - During the year ended
December 31, 2025 , the Company completed a like-kind exchange involving the transfer of its dispensary located inMokena, IL for a dispensary located inBrookville, PA. - On
March 4, 2026 , the Company’s board of directors declared a first quarter 2026 dividend of$0.43 per share of common stock.
Balance Sheet Highlights as of
- Cash and cash equivalents as of
December 31, 2025 were$23.9 million , with approximately$0.4 million committed to fund improvements at an existing dispensary inOhio . - Total liquidity of
$106.3 million , consisting of cash and cash equivalents and availability under the Company’s Revolving Credit Facility. - Gross real estate assets of
$432.9 million , including one property classified as Real Estate Held for Sale. - 1.6% debt to total gross assets and a debt service coverage ratio of approximately 77.9x.
- No debt maturities until
May 2027 .
________________________________________________________________________________
(1) FFO and AFFO are presented on a dilutive basis.
Financial Results
The following table summarizes the Company's financial results for the three and twelve months ended
| Three Months Ended | Twelve Months Ended | |||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||
| Revenue | $ | 12,343 | 12,514 | $ | 51,071 | 50,131 | ||||||
| Net Income Attributable to Common Stockholders | $ | 6,036 | $ | 6,029 | $ | 26,318 | $ | 26,115 | ||||
| Net Income Attributable to Common Stockholders Per Share - Diluted | $ | 0.29 | $ | 0.29 | $ | 1.28 | $ | 1.27 | ||||
| FFO Attributable to Common Stockholders - Diluted | $ | 10,020 | $ | 9,922 | $ | 42,305 | $ | 41,278 | ||||
| FFO Per Share – Diluted | $ | 0.48 | $ | 0.47 | $ | 2.02 | $ | 1.97 | ||||
| AFFO Attributable to Common Stockholders - Diluted | $ | 10,624 | $ | 10,949 | $ | 43,823 | $ | 43,689 | ||||
| AFFO Per Share – Diluted | $ | 0.51 | $ | 0.52 | $ | 2.09 | $ | 2.08 | ||||
For the three months ended
For the year ended
2025 Investment Activity
Acquisitions
The following table presents the Company's investment activity for the twelve months ended
| Tenant | Market | Site Type | Closing Date | Acquisition | |||||
| Cresco Labs | Dispensary | $ | 285 | ||||||
| Cresco Labs | Dispensary | 500 | |||||||
| Curaleaf | (1) | Dispensary | 950 | ||||||
| Total | $ | 1,735 | |||||||
(1) This dispensary was acquired through a like-kind exchange and was recorded at its fair value.
Real Estate Commitments
Improvement Allowances
The following table presents the funded and remaining unfunded commitments for the twelve months ended
| Tenant | Market | Site Type | Closing Date | Funded Commitments | Unfunded Commitments | |||||||
| Cresco Labs | Dispensary | $ | 705 | $ | — | |||||||
| Cresco Labs | Dispensary | — | 375 | |||||||||
| Total | $ | 705 | $ | 375 | ||||||||
Portfolio and Tenant Updates
In
Financing Activity
Revolving Credit Facility
As of
As of
Dividend
On
For the year ended
On
Conference Call and Webcast Details:
Management will host a conference call and webcast at
| Event: | |
| Date: | |
| Time: | |
| Live Call: | 1-877-407-3982 ( |
| Webcast: | https://ir.newlake.com/news-events/ir-calendar |
For interested individuals unable to join the conference call, a dial-in replay of the call will be available until
About
Forward-Looking Statements
This press release contains “forward-looking statements.” Forward-looking statements can be identified by words like “may,” “will,” “likely,” “should,” “expect,” “anticipate,” “future,” “ongoing,” “plan,” “believe,” “intend,” “goal,” “project,” “continue” and similar expressions. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs and expectations. Forward-looking statements are based on the Company’s current expectations and assumptions regarding capital market conditions, the Company’s business, tenant performance, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a discussion of the risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. The Company does not undertake, and specifically disclaims any obligation, to publicly release the result of any revisions which may be made to any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements, except as required by law.
Use of Non-GAAP Financial Information
FFO and AFFO are supplemental non-GAAP financial measures used in the real estate industry to measure and compare the operating performance of real estate companies. A complete reconciliation containing adjustments from GAAP net income attributable to common stockholders to FFO and AFFO and definitions of terms are included at the end of this release.
Contact Information:
Chief Financial Officer, Treasurer and Secretary
lmeyer@newlake.com
Investor Contact:
NewLake@KCSA.com
PH: (212) 896-1254
Media Contact:
EMellody@KCSA.com
PH: (570) 209-2947
CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share amounts) | |||||||
2025 | 2024 | ||||||
| Assets: | |||||||
| Real Estate | |||||||
| Land | $ | 22,903 | $ | 22,891 | |||
| Building and Improvements | 404,983 | 408,552 | |||||
| 427,886 | 431,443 | ||||||
| Less Accumulated Depreciation | (57,916 | ) | (44,709 | ) | |||
| 369,970 | 386,734 | ||||||
| Real Estate Held for Sale | 4,802 | - | |||||
| Cash and Cash Equivalents | 23,937 | 20,213 | |||||
| In-Place Lease Intangible Assets, net | 15,710 | 17,794 | |||||
| Loan Receivable, net (current expected credit loss | 4,929 | 4,884 | |||||
| Other Assets | 1,481 | 1,911 | |||||
| Total Assets | $ | 420,829 | $ | 431,536 | |||
| Liabilities and Equity: | |||||||
| Liabilities: | |||||||
| Accounts Payable and Accrued Expenses | $ | 1,307 | $ | 1,515 | |||
| Revolving Credit Facility | 7,600 | 7,600 | |||||
| Dividends and Distributions Payable | 9,169 | 9,246 | |||||
| Security Deposits | 6,728 | 8,117 | |||||
| Rent Received in Advance | 1,013 | 684 | |||||
| Other Liabilities | 324 | 402 | |||||
| Total Liabilities | 26,141 | 27,564 | |||||
| Equity: | |||||||
| Preferred Stock, | - | - | |||||
| Common Stock, | 205 | 205 | |||||
| 447,185 | 446,627 | ||||||
| Accumulated Deficit | (59,449 | ) | (50,067 | ) | |||
| Total Stockholders' Equity | 387,941 | 396,765 | |||||
| Noncontrolling Interests | 6,747 | 7,207 | |||||
| Total Equity | 394,688 | 403,972 | |||||
| Total Liabilities and Equity | $ | 420,829 | $ | 431,536 | |||
CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except share and per share amounts) | |||||||||||||||
| For the Three Months Ended | For the Twelve Months Ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Revenue: | |||||||||||||||
| Rental Income | $ | 12,052 | $ | 12,270 | $ | 49,537 | $ | 48,926 | |||||||
| Interest Income from Loans | 137 | 134 | 545 | 533 | |||||||||||
| Fees and Reimbursables | 154 | 110 | 989 | 672 | |||||||||||
| Total Revenue | 12,343 | 12,514 | 51,071 | 50,131 | |||||||||||
| Expenses: | |||||||||||||||
| Reimbursable Property Expenses | 98 | 60 | 811 | 239 | |||||||||||
| Property Carrying Costs | 229 | — | 379 | — | |||||||||||
| Depreciation and Amortization Expense | 3,886 | 3,792 | 15,520 | 14,713 | |||||||||||
| General and Administrative Expenses: | |||||||||||||||
| Compensation Expense | 960 | 1,120 | 3,768 | 4,675 | |||||||||||
| Professional Fees | 287 | 387 | 1,424 | 1,506 | |||||||||||
| Other General and Administrative Expenses | 616 | 427 | 1,929 | 1,733 | |||||||||||
| Total General and Administrative Expenses | 1,863 | 1,934 | 7,121 | 7,914 | |||||||||||
| Total Expenses | 6,076 | 5,786 | 23,831 | 22,866 | |||||||||||
| Loss on Sale of Real Estate | — | — | (34 | ) | — | ||||||||||
| Provision for Current Expected Credit Loss | 11 | 13 | 45 | 51 | |||||||||||
| Impairment Loss on Warrants | — | (522 | ) | — | (522 | ) | |||||||||
| Income From Operations | 6,278 | 6,219 | 27,251 | 26,794 | |||||||||||
| Other Income (Expense): | |||||||||||||||
| Other Income | 83 | 92 | 357 | 354 | |||||||||||
| Interest Expense | (223 | ) | (177 | ) | (839 | ) | (565 | ) | |||||||
| Total Other Income (Expense) | (140 | ) | (85 | ) | (482 | ) | (211 | ) | |||||||
| Net Income | 6,138 | 6,134 | 26,769 | 26,583 | |||||||||||
| Net Income Attributable to Noncontrolling Interests | (102 | ) | (105 | ) | (451 | ) | (468 | ) | |||||||
| Net Income Attributable to Common Stockholders | $ | 6,036 | $ | 6,029 | $ | 26,318 | $ | 26,115 | |||||||
| Net Income Attributable to Common Stockholders Per Share - Basic | $ | 0.29 | $ | 0.29 | $ | 1.28 | $ | 1.27 | |||||||
| Net Income Attributable to Common Stockholders Per Share - Diluted | $ | 0.29 | $ | 0.29 | $ | 1.28 | $ | 1.27 | |||||||
| Weighted Average Shares of Common Stock Outstanding - Basic | 20,629,734 | 20,580,337 | 20,617,807 | 20,564,179 | |||||||||||
| Weighted Average Shares of Common Stock Outstanding - Diluted | 21,021,427 | 20,984,471 | 20,991,540 | 20,963,532 | |||||||||||
Non-GAAP Financial Information
Funds From Operations
The Company calculates FFO in accordance with the current
Adjusted Funds From Operations
The Company calculates AFFO by starting with FFO and adjusting for non-cash and certain non-recurring transactions, including non-cash components of compensation expense and the effect of provisions for credit losses. Other REITs may not define AFFO in the same manner and therefore the Company’s calculation of AFFO may not be comparable to such other REITs. You should not consider FFO and AFFO to be alternatives to net income as a reliable measure of our operating performance; nor should you consider FFO and AFFO to be alternatives to cash flows from operating, investing or financing activities (as defined by GAAP) as measures of liquidity.
The table below is a reconciliation of net income attributable to common stockholders to FFO and AFFO for the three and twelve months ended
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net Income Attributable to Common Stockholders | $ | 6,036 | $ | 6,029 | $ | 26,318 | $ | 26,115 | |||||||
| Net Income Attributable to Noncontrolling Interests | 102 | 105 | 451 | 468 | |||||||||||
| Net Income | 6,138 | 6,134 | 26,769 | 26,583 | |||||||||||
| Adjustments: | |||||||||||||||
| Real Estate Depreciation and Amortization | 3,882 | 3,788 | 15,502 | 14,695 | |||||||||||
| Loss on Sale of Real Estate | — | — | 34 | — | |||||||||||
| FFO Attributable to Common Stockholders - Diluted | 10,020 | 9,922 | 42,305 | 41,278 | |||||||||||
| Impairment Loss on Warrants | — | 522 | — | 522 | |||||||||||
| Non-cash Write-off of Deferred Offering Costs | 233 | — | 233 | — | |||||||||||
| Provision for current expected credit loss | (11 | ) | (13 | ) | (45 | ) | (51 | ) | |||||||
| Stock-Based Compensation | 316 | 452 | 1,066 | 1,674 | |||||||||||
| Non-Cash Interest Expense | 67 | 67 | 269 | 269 | |||||||||||
| Amortization of Straight-Line Rent Expense | (1 | ) | (1 | ) | (5 | ) | (3 | ) | |||||||
| AFFO Attributable to Common Stockholders - Diluted | $ | 10,624 | $ | 10,949 | $ | 43,823 | $ | 43,689 | |||||||
| FFO per share - Diluted | $ | 0.48 | $ | 0.47 | $ | 2.02 | $ | 1.97 | |||||||
| AFFO per share - Diluted | $ | 0.51 | $ | 0.52 | $ | 2.09 | $ | 2.08 | |||||||
Source: 